<?xml version="1.0" encoding="UTF-8"?>
<p>The infection rate
 <sup>
  <xref rid="b6-1040797" ref-type="bibr">6</xref>,
  <xref rid="b8-1040797" ref-type="bibr">8</xref>,
  <xref rid="b10-1040797" ref-type="bibr">10</xref>,
  <xref rid="b34-1040797" ref-type="bibr">34</xref>
 </sup> was comparable to previous clinical studies with an expected higher infection rate for FCR. Our study showed an incidence of RT in line with previous data.
 <sup>
  <xref rid="b32-1040797" ref-type="bibr">32</xref>,
  <xref rid="b38-1040797" ref-type="bibr">38</xref>â€“
  <xref rid="b40-1040797" ref-type="bibr">40</xref>
 </sup> However, our study did not, in contrast to previous data,
 <sup>
  <xref rid="b38-1040797" ref-type="bibr">38</xref>,
  <xref rid="b41-1040797" ref-type="bibr">41</xref>
 </sup> show any association between treatment with fludarabine and RT. The slightly lower incidence of RT within the CLB group may be because the median time to transformation was three years, and the patients in this group were older and had a shorter median OS.
</p>
